Longhorn Vaccines and Diagnostics has announced that the company has collaborated with Greenfield Global to speed up the Covid-18 detection and testing methods. The recent outbreak of Covid-19 pandemic requires the adequate testing of several devices, including the viral transport medium, Biosafety equipment, to keep the virus alive within the required sample refrigeration.
The PrimeStore MTM of LongHorn safely deactivates pathogens and stabilizes the DNA and RNA, allowing enhanced ambient temperature transport and it needs no extra special containment facilities.
Chief Scientific Officer at Longhorn Vaccines and Diagnostics and the inventor of PrimeStore MTM. Dr. Luke Daum said, “Safe and robust collection of high-quality samples that can be processed on standard lab benches using conventional qPCR have enabled rapid detection from patients and assisted in combating the global COVID19 pandemic.”
“What makes PrimeStore MTM® so important is that once an oral or nasal swab is collected, the viruses and bacteria from the sample are lysed/inactivated, the RNA and DNA are stabilized for safe transport and processing outside of BSL-2/3 laboratories,” Dr. Luke further added.
Senior Vice President of Sales & Operations, Steve DiBenedetto said, “Formulating solvents that meet our customers’ criteria allows us to help them make incredible products and meet the demands of the market. Our Pharmco branded products are blended and packaged at our GMP-compliant facilities operating under an ISO 9001:2015 Quality Management System which ensures a high quality, consistent product.”
“Longhorn Vaccines and Diagnostic Testing’s innovation is remarkable. We value their trust in our top-quality products, our security of supply, and our reliable supply chain, which allows us to help support millions of critical tests worldwide.” PrimeStore MTM® is an FDA-cleared collection medium for respiratory samples, including SARS-CoV-2 virus and has emerged to become a critical tool in the fight against COVID19,” Steve further added.